Entity
  • Ascend Advanced Therapies

    Created in 2021
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    8,500
  • Activities

  • Technologies

  • Entity types

  • Location

    London, UK

    London

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 115

  • Engaged corporates

    2
    0 2
  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics.

    Ascend is a development partner that supports life-science innovators in bringing gene therapy products to patients.

    Our team has deep expertise in gene therapy development and commercialization to offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested in a world-class analytical toolkit within our flexible and scalable AAV platform of next-gen technologies, all built to find the perfect balance of yield and quality for each process.

    Let’s aim higher and develop the next wave of accessible life-saving therapies together!

Corporate interactions BETA
Corporate TypeTweets Articles
Financial Times
Financial Times
Media, Newspaper Publishing
Financial Times
Media, Newspaper Publishing
Other

29 Feb 2024


HSBC
HSBC
Bank, Financial Services
HSBC
Bank, Financial Services
Other

31 Jan 2024


Similar entities
Loading...
Loading...
Social network dynamics